Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-05

Clinical Trial Update: Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing axillary lymph node dissection to no dissection in breast cancer with a positive sentinel lymph node has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Breast Cancer | Phase 3 | Status: WITHDRAWN